| Metric | Q2'25 | Q3'25 | Change |
|---|---|---|---|
| Total Revenue | Q2: 11% YoY growth | Q3: 14% YoY growth | +300 bps acceleration |
| Current RPO Growth | Q2: 9% YoY | Q3: 13% YoY | +400 bps acceleration |
| Total RPO Growth | Q2: 15% YoY | Q3: 19% YoY | +400 bps acceleration |
| Non-GAAP Operating Margin | Q2: Record profitability | Q3: 23% guided for Q4 | Sustained high profitability |
| Free Cash Flow Margin | Q2: Strong cash flow | Q3: ~32% guided for Q4 | Exceptional cash generation |
| $1M+ ACV Cohort | Q2: Fastest growing cohort | Q3: Now represents ~$1 billion in ACV | Hit $1B milestone |
| New Products Bookings Mix | Q2: Not disclosed | Q3: 15% of bookings | First quantified disclosure |
| Partner Revenue Mix | Q2: Over 40% | Q3: All top 10 deals had partners | 100% penetration in large deals |
| Federal Vertical Performance | Q2: Area of strength | Q3: Half of top 10 deals | 50% concentration in large deals |
| OIG Customer Count | Q2: Over 1,000 customers | Q3: Close to 1,000 customers | Slight language softening |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.